Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders. The Annual Meeting of Stockholders of Iradimed Corporation (“Iradimed”) was held on Tuesday, June 23, 2026. At the meeting, Iradimed’s stockholders voted on the following three proposals and cast their votes as described below. 1.…
Filed Jun 24, 2026Accepted Jun 24, 2026, 10:22 AM EDTCIK 1325618Accession 0001628280-26-045059
IRADIMED CORPORATION is a leader in developing innovative Magnetic Resonance Imaging (“MRI”) compatible medical devices. We design, manufacture, market, and distribute MRI-compatible medical devices, accessories, disposables, and related services. We are the only known provider of a non-magnetic intravenous (“IV”) infusion pump system specifically designed to be safe for use during MRI procedures. We were the first to develop an infusion delivery system that largely eliminates many of the dangers and problems present during MRI procedures. Standard infusion pumps contain magnetic and electronic components that can create radio frequency interference and are dangerous to operate in the presence of the powerful magnet that drives an MRI system. Our patented MRidium® MRI compatible IV infusion pump system has a non-magnetic ultrasonic motor, uniquely designed non-ferrous parts, and other special features to safely and predictably deliver anesthesia and other IV fluids during various MRI procedures. Our pump solution provides a seamless approach that enables accurate, safe, and dependable fluid delivery before, during, and after an MRI scan, which is essential to critically ill patients who cannot be removed from their vital medications and children and infants who must generally be sedated to remain immobile during an MRI scan.
Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 5.07Item 5.07 - Submission of Matters to Vote
Item 5.07
Submission of Matters to a Vote of Security Holders.
The Annual Meeting of Stockholders of Iradimed Corporation (“Iradimed”) was held on Tuesday, June 23, 2026. At the meeting, Iradimed’s stockholders voted on the following three proposals and cast their votes as described below.
1. Stockholders elected each of Roger Susi, Monty Allen, Joe Kiani, Hilda Scharen-Guivel and James Hawkins to Iradimed’s Board of Directors, each to hold office until a succeeding annual meeting of stockholders or until such director’s successor shall have been duly elected and qualified (or, if earlier, such director’s removal or resignation from our Board), as set forth below.
Name Votes For Votes Withheld Broker Non-Votes
──────────────────────────────────────────────────────────────────────────────────
Roger Susi 8,638,178 1,972,758 759,594
Monty Allen 9,266,549 1,344,387 759,594
Joe Kiani 10,492,206 118,730 759,594
Hilda Scharen-Guivel 10,409,481 201,455 759,594
James Hawkins 8,244,802 2,366,134 759,594
2. Stockholders ratified the selection of RSM US LLP as Iradimed’s independent registered public accounting firm to perform independent audit services for the fiscal year ending December 31, 2026, as set forth below.
Votes For Votes Against Abstentions
──────────────────────────────────────────────────
11,355,891 8,716 5,923
3. Stockholders approved an advisory resolution on the compensation of Iradimed’s named executive officers.
Votes For Votes Against Abstentions Broker Non-Votes
────────────────────────────────────────────────────────────────────────
10,487,387 106,030 17,519 759,594